Evercore ISI lowered the firm’s price target on Thermo Fisher to $600 from $615 and keeps an Outperform rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered to $600 from $615 at Barclays
- Twist extends rally as Wall Street sees opportunity amid GenScript scrutiny
- Best Buy upgraded, Target initiated: Wall Street’s top analyst calls
- Thermo Fisher assumed with Buy from Hold at Jefferies
- 3 Best Non-Nvidia AI Stocks to Buy in May 2024, as per Analysts